News
"Recognify’s Phase IIb trial of schizophrenia therapy fails to meet primary goal" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
GeniPhys, a preclinical-stage company developing regenerative biomaterials for soft tissue restoration, has been awarded a $500,000 NSF SBIR Phase IIB supplemental funding grant.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback